How The OptimizeRx (OPRX) Narrative Is Shifting As Revenue Caution Meets Profit Optimism [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
OptimizeRx's blended fair value estimate remains steady at US$14.50 per share, so the latest update is more about fine tuning assumptions than resetting the overall price target. That stability comes as Street research turns more cautious on the revenue outlook through 2026, even while bullish analysts highlight stronger profitability trends and the new US$10m buyback. Read on to see what is behind this split view and how to track the story as the narrative around OptimizeRx continues to evolve. Stay updated as the Fair Value for OptimizeRx shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on OptimizeRx. What Wall Street Has Been Saying ?? Bullish Takeaways Lake Street, Stifel and Roth Capital all keep Buy ratings in place, signaling that they still see value in OptimizeRx shares even after revising assumptions. Lake Street highlights improved profit forecasts and points to the new US$10m share repurchase
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx Appoints Mary Varghese Presti to Board of Directors [Yahoo! Finance]Yahoo! Finance
- OptimizeRx Appoints Mary Varghese Presti to Board of DirectorsGlobeNewswire
- How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice [Yahoo! Finance]Yahoo! Finance
- OptimizeRx (OPRX) was upgraded by Zacks Research from "hold" to "strong-buy".MarketBeat
- OptimizeRx: Q4 Earnings Report Indicates Caution For 2026 [Seeking Alpha]Seeking Alpha
OPRX
Earnings
- 3/5/26 - Beat
OPRX
Sec Filings
- 4/9/26 - Form 8-K
- 3/30/26 - Form 8-K
- 3/27/26 - Form SCHEDULE
- OPRX's page on the SEC website